Abstract 5184: Anti-HVEM mAb therapy improves antitumoral immunity both <i>in vitro</i> and <i>in vivo</i>, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

Authors: Laurent GORVEL, Clemence Demerle, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frederic Fiore, Jacques Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Herve Luche, Fabrice Barlesi, Daniel Olive

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-5184

Source: Full article